Olsson C - Search Results

1

One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume^® Drug-Coated Balloon for Anterior Urethral Strictures.

Elliott SP, Coutinho K, Robertson KJ, D'Anna R, Chevli K, Carrier S, Aube-Peterkin M, Cantrill CH, Ehlert MJ, Te AE, Dann J, DeLong JM, Brandes SB, Hagedorn JC, Levin R, Schlaifer A, DeSouza E, DiMarco D, Erickson BA, Natale R, Husmann DA, Morey A, Olsson C, Virasoro R. Elliott SP, et al. Among authors: olsson c. J Urol. 2022 Apr;207(4):866-875. doi: 10.1097/JU.0000000000002346. Epub 2021 Dec 2. J Urol. 2022. PMID: 34854748 Clinical Trial.

2

Reply by Authors.

Elliott SP, Coutinho K, Robertson KJ, D'Anna R, Chevli K, Carrier S, Aube-Peterkin M, Cantrill CH, Ehlert MJ, Te AE, Dann J, DeLong JM, Brandes SB, Hagedorn JC, Levin R, Schlaifer A, DeSouza E, DiMarco D, Erickson BA, Natale R, Husmann DA, Morey A, Olsson C, Virasoro R. Elliott SP, et al. Among authors: olsson c. J Urol. 2022 Apr;207(4):875. doi: 10.1097/JU.0000000000002346.03. Epub 2021 Dec 29. J Urol. 2022. PMID: 34963298 No abstract available.

3

Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.

Kaplan SA, Te AE, Pressler LB, Olsson CA. Kaplan SA, et al. Among authors: olsson ca. J Urol. 1995 Nov;154(5):1764-9. J Urol. 1995. PMID: 7563342 Free article. Clinical Trial.

4

The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?

Kaplan SA, Olsson CA, Te AE. Kaplan SA, et al. Among authors: olsson ca. J Urol. 1996 Jun;155(6):1971-4. J Urol. 1996. PMID: 8618299 Free article.

5

Differential diagnosis of prostatism: A 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy.

Kaplan SA, Bowers DL, Te AE, Olsson CA. Kaplan SA, et al. Among authors: olsson ca. J Urol. 1996 Apr;155(4):1305-8. doi: 10.1016/s0022-5347(01)66252-9. J Urol. 1996. PMID: 8632561 Free article.

6

Neurotrophic factors in the rat penis.

Te AE, Santarosa RP, Koo HP, Buttyan R, Greene LA, Kaplan SA, Olsson CA, Shabsigh R. Te AE, et al. Among authors: olsson ca. J Urol. 1994 Dec;152(6 Pt 1):2167-72. doi: 10.1016/s0022-5347(17)32345-5. J Urol. 1994. PMID: 7966709 Free article.

7

Up and Away: Five Decades of Urologic Investigation in Microgravity.

Leapman MS, Jones JA, Coutinho K, Sagalovich D, Garcia MM, Olsson CA, Stock JA. Leapman MS, et al. Urology. 2017 Aug;106:18-25. doi: 10.1016/j.urology.2017.03.012. Epub 2017 May 8. Urology. 2017. PMID: 28495507 Review.

8

Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia.

Kaplan SA, Goluboff ET, Olsson CA, Deverka PA, Chmiel JJ. Kaplan SA, et al. Among authors: olsson ca. Urology. 1995 Mar;45(3):398-405. doi: 10.1016/S0090-4295(99)80007-7. Urology. 1995. PMID: 7533451 Clinical Trial.

9

Effect of dosing regimen on efficacy and safety of doxazosin in normotensive men with symptomatic prostatism: a pilot study.

Kaplan SA, Soldo KA, Olsson CA. Kaplan SA, et al. Among authors: olsson ca. Urology. 1994 Sep;44(3):348-52. doi: 10.1016/s0090-4295(94)80092-8. Urology. 1994. PMID: 7521090 Clinical Trial.

10

Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safety.

Kaplan SA, Soldo KA, Olsson CA. Kaplan SA, et al. Among authors: olsson ca. Eur Urol. 1995;28(3):223-8. doi: 10.1159/000475055. Eur Urol. 1995. PMID: 8536776 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

933 results

Search Page